The Column Group

About

The Column Group | TCG Skip to content Main Menu Your browser does not support the video tag. Where Bold Ventures Drive Therapeutic Breakthroughs The Column Group (TCG) is a venture ecosystem dedicated to fueling scientific innovation in the life sciences industry. Cultivating New Frontiers of Science Across its two-decade history, TCG has funded key advancements within biotechnology, nurturing science into successful ventures and therapeutic breakthroughs. Fueling Life Sciences Innovation Across the Life Cycle of Opportunity TCG deploys an edge-to-edge investment model, harnessing an ecosystem of funds that propel early technology platforms, single assets and later-stage programs forward from inception through exit. Returns $ Billion TCG has generated $4.0 billion in returns for its partners and portfolio. Innovation Companies Across its two-decade history, TCG has nurtured science into successful biotech ventures, having started and invested in 55 companies. Impact Exits TCG has funded key advancements within biology, chemistry and technology, leading to 18 company exits. The TCG Ecosystem Pursuing the Unprecedented TCG takes a novel approach to venture capital funding with an edge-to-edge investment model primarily focused on company formation but with the financial wherewithal for long-term private and public capital support. This model exists within an ecosystem of funds, each with a clear strategy and focus, and all with a mandate of maximizing success through collabora

Key Contact